Get the weekly note
ETFIQetfiq.com · independent ETF data

Data as of .

BBH vs FBT: which is really different?

BBH and FBT hold 45% of their weight in the same names, and FBT returned more over the year.

VanEck Biotech ETF and First Trust NYSE Arca Biotechnology Index Fund.

60.4%BBH in the S&P 500
23.6%FBT in the S&P 500
+40.5%BBH total return, 1 year
+48.9%FBT total return, 1 year

ETFIQ Off-Index Score: FBT scores higher

How much of it is not the index it is sold as an alternative to?

BBH 61.7FBT 64.10.1, the lowest in this set91.8, the highest

A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed

BBH40% of its weight is outside the S&P 500 · 1 year to Sep 18, 2026
60%40%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 99% · top ten 72% of the fund · 24 holdings filed Sep 17, 2026 · Nasdaq-100: 47% in60%40%in the S&P 500outsideactive share 99% · top ten 72% of the fund
FBT76% of its weight is outside the S&P 500 · 1 year to Sep 18, 2026
24%76%in the S&P 500of its weight outside the S&P 500active share 99% · top ten 39% of the fund · 31 holdings filed Sep 18, 2026 · Nasdaq-100: 16% in24%76%inoutside the S&P 500active share 99% · top ten 39% of the fund

45% of the two portfolios are the same securities at the same weight.

What they hold in common

By the books each fund has filed, BBH and FBT hold 45% of their money in the same securities at the same weight.

Positions BBH and FBT both hold, largest shared weight first
HoldingBBHFBT
Natera Inc4.97%4.24%
Illumina Inc3.68%3.90%
Regeneron Pharmaceuticals Inc7.00%3.66%
Gilead Sciences Inc13.81%3.58%
Argenx Se4.93%3.50%
Amgen Inc15.03%3.29%
Vertex Pharmaceuticals Inc8.32%3.24%
Beone Medicines Ltd2.75%3.64%
Biogen Inc2.71%3.35%
Alnylam Pharmaceuticals Inc2.73%2.48%
Incyte Corp2.39%3.33%
United Therapeutics Corp2.12%2.80%
Only in each
Only in BBHOnly in FBT
Moderna Inc 5.05%Halozyme Therapeutics, Inc. 4.57%
Iqvia Holdings Inc 4.61%NeoGenomics, Inc. 4.37%
Revolution Medicines Inc 4.09%Repligen Corporation 3.80%
Guardant Health Inc 3.15%Corcept Therapeutics Inc. 3.72%
Insmed Inc 2.31%Genmab A/S (ADR) 3.71%
Charles River Laboratories Internationa 1.48%Sarepta Therapeutics, Inc. 3.29%
Icon Plc 1.25%Exelixis, Inc. 3.20%
Tempus Ai Inc 1.10%Bruker Corporation 3.17%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Sep 18, 2026.

Performance, window by window

BBH and FBT over each window. Every figure is an ETFIQ calculation with distributions reinvested. Source: ETFIQ.
WindowTotal returnvs the S&P 500vs the Nasdaq-100
BBHFBTBBHFBTBBHFBT
3 months+24.8%+17.2%+22.5 pts+14.9 pts+27.3 pts+19.6 pts
6 months+29.0%+40.6%+11.0 pts+22.6 pts+4.8 pts+16.4 pts
1 year+40.5%+48.9%+23.9 pts+32.3 pts+18.7 pts+27.1 pts
3 years+48.9%+80.7%−29.5 pts+2.3 pts−49.3 pts−17.5 pts
Since launch+732.7%+848.2%−70.8 pts+44.6 pts−957.5 pts−842.1 pts
Open the live comparison on ETFIQ
BBH and FBT on the same fields, as of Sep 18, 2026. Source: ETFIQ.
BBH
VanEck Biotech ETF
Holds 24 stocks in biotech, 60% of its weight in S&P 500 companies
FBT
First Trust NYSE Arca Biotechnology Index Fund
Holds 31 stocks in biotech, 24% of its weight in S&P 500 companies
IssuerVanEckFirst Trust
ThemeBiotechBiotech
In the S&P 50060.4%23.6%
Active share vs the S&P 50099.0%99.1%
In the Nasdaq-10047.2%16.2%
Holdings2431
Top ten, share of the fund72.4%39.2%
Expense ratio0.35%0.55%
Fee for the differing part0.35%0.55%
Total return, 1 year+40.5%+48.9%
vs the S&P 500+23.9 pts+32.3 pts
vs the Nasdaq-100+18.7 pts+27.1 pts
Below its high−4.0%−2.1%
Net assets$470m$2.9bn

BBH in plain words

By weight, 60% of BBH's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 72% of the fund across 24 positions, as published by its issuer for Sep 18, 2026. Over the year to Sep 18, 2026 the fund returned +40.5% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 23.9 pts.

FBT in plain words

By weight, 24% of FBT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 39% of the fund across 31 positions, as published by its issuer for Sep 18, 2026. Over the year to Sep 18, 2026 the fund returned +48.9% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 32.3 pts.

Questions people ask

Do BBH and FBT hold the same stocks?
By their latest filings, 45% of their books are the same securities at the same weight, which is a meaningful overlap. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, BBH or FBT?
BBH has 60% of its weight in S&P 500 names and FBT has 24%, so FBT differs more from the index.
Which is cheaper, BBH or FBT?
BBH charges 0.35% a year and FBT charges 0.55%, so BBH is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

BBH against FBT, ETFIQ, data as of Sep 18, 2026. Every figure is calculated from a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, BBH against FBT, data as of Sep 18, 2026. https://etfiq.com/compare/themes/bbh-vs-fbt Free to use with attribution; the underlying files are at Open data.

How every figure is computed · Standards and sources